JAKARTA, Sept 7 (Reuters) - Indonesia has approved the single-dose COVID-19 vaccines produced by Janssen Pharmaceutical Companies, part of Johnson & Johnson, and China's CanSino Biological Inc for emergency use, the country's food and drug agency said in a statement on Tuesday. (Reporting by Stanley Widianto; Writing by Gayatri Suroyo Editing by Ed Davies)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.5 HKD | -6.88% | -7.09% | -29.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.94% | 998M | |
-5.99% | 83.66B | |
+2.76% | 40.41B | |
-24.88% | 28.26B | |
+53.61% | 24.53B | |
-8.08% | 16.82B | |
-33.74% | 13.39B | |
-16.63% | 11.75B | |
-11.19% | 11.69B | |
-2.25% | 8.13B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- CanSino Biologics : Indonesia approves J&J, Cansino COVID-19 vaccines for emergency use